Does growth hormone therapy benefit body composition and glucose homeostasis in girls with Turner syndrome?

Nature Clinical Practice Endocrinology and Metabolism

Volumn 4, Issue 11, 2008, Pages 596-597

  Lo, Janet ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Fat distribution; Growth hormone; Impaired glucose tolerance; Insulin; Turner syndrome

Indexed keywords

GROWTH HORMONE; PLACEBO;

ABDOMINAL FAT; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL TRIAL; DIABETES MELLITUS; DRUG EFFECT; ETHNICITY; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HORMONAL THERAPY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; KARYOTYPE; NOTE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TURNER SYNDROME;

EID: 54549090885     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0954     Document Type: Note

References (7)

1. Sybert VP and McCauley E (2004) Turner's syndrome. N Engl J Med 351:1227-1238
2. Caprio S et al. (1991) Insulin resistance: an early metabolic defect of Turner's syndrome. J Clin Endocrinol Metab 72: 832-836
3. Gravholt CH et al. (2002) Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study. Pediatrics 110: 889-896
4. Van Pareren YK et al.(2002) Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome. J Clin Endocrinol Metab 87: 5442-5448
5. Wooten N et al. (2008) Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome. J Clin Endocrinol Metab 93: 2109-2114
6. Ross JL et al. (1985) Growth hormone secretory dynamics in Turner syndrome. J Pediatr 106: 202-206
7. Gravholt CH et al. (2001) Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids. Am J Physiol Endocrinol Metab 280: E308-E314